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1. Introduction
  The adverse effects of anemia in pregnancy on both 
mother and the growing fetus are well documented. 
Hemoglobin being a driving force for oxygen and nutrients 
for both mother and fetus, a reduction below acceptable 
levels can be detrimental to both. With World Health 
Organization (WHO) definition of anemia in pregnancy of 
hemoglobin concentration below 11.0 g/dL or packed cell 
volume (PCV)  less than 33.0%, anemia is  the commonest 
medical condition encounter in pregnancy[1,2], while in 
most developing countries the burden of this problem is 
often under estimated[2,3]. About half of all pregnant women 
worldwide are anemic with over two third of them residing 
in the developing countries[4-6]. The commonest identified 
causes of anemia include excessively rapid destruction of 
red blood cells, bleeding during pregnancy, inadequate 
hematopoeisis and infections such as HIV[3,4,7]. 
  Though micro- and macro- nutritional (iron, folate and 
vitamins) deficiencies are usually implicated in Sub-
Saharan African countries[6-8], the importance of acute 
severe symptomatic malarial infestations on anemia are 
also well recognized[9-11], but the impact of asymptomatic 
parasitemia on this disease is often not fully appreciated 
nor emphasized[11]. Though the main mechanism why 
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malaria causes anemia is not very clear, increase hemolysis 
of parasitized and non-parasitized red blood cells are 
suggested[10]. Severe placental infestations are presented 
even in asymptomatic patients with low parasitemia while 
serious maternal and perinatal consequences[10-14]. 
Immunological and other unknown mechanisms are also 
involved[13].  Though general adults living in endemic areas 
acquire protective immunity against developing severe 
malaria, many pregnant women still remain asymptomatic 
,even with severe parasitemia. Despite, absence of maternal 
malarial symptoms, high placental parasitemia is still 
present with associated perinatal complications[12,13,15].
  Therefore, in areas with stable malaria like Akwa Ibom 
State of Nigeria, majority of infestations with Plasmodium 
falciparum in pregnancy may remain asymptomatic, 
undetected and untreated[9,15]. Effective treatment of 
asymptomatic malaria in pregnant has been shown to reduce 
maternal and perinatal complications associated with the 
disease[14,15]. Consequently, because of the impact of this 
disease on the health and productive capacity of the patients 
in our society, most people including pregnant women 
often take antimalarial medications (both orthodox and 
traditional preparations) without prescriptions by qualified 
personnel[16,17]. These medications do not seem to show 
much positive impacts in reducing parasite density and 
improving anemia. The reported high prevalence of malaria 
disease in the Niger Delta region of Nigeria like Akwa Ibom 
State coupled with the lack of sufficient data on impact of 
asymptomatic malarial parasitemia in pregnancy prompted 
this study to document baseline data and information on 
malaria in pregnancy in the area.
  This study was therefore conducted in the General 
Hospital, Ikot Ekpene, Akwa Ibom State of Nigeria with 
aims of determining the baseline prevalence of anemia in 
asymptomatic malaria parasitemia in pregnant women  and 
to assess the impact of wide spread  intake of antimalarial 
medications on the density of parasitemia. It is hoped 
that the result of this study will assist the government and 
other stakeholders to assess the effect of current malarial 
preventive strategies and other initiatives on the burden of 
the disease on pregnant women in the rural areas in Nigeria.
2. Materials and methods
2.1. Subjects and setting
  This prospective study was conducted in the antenatal 
clinic of General Hospital, Ikot Ekpene, Akwa Ibom 
State of Nigeria over a three month period (1st June to 1st 
August, 2009). The hospital is a secondary level referral 
health care facility in the state which is located in the Niger 
Delta region of Nigeria. The hospital has an estimated 500 
antenatal women per month and an annual delivery of 1 200 
maternities.
  After an ethical permission was obtained from the relevant 
authority in the hospital, and unwritten informed consent 
from the women who participated in the study a pre-tested 
semi structured questionnaire was administered to each of 
them by the authors to obtain demographic and reproductive 
information. The information obtained included age, social 
status, parity, menstrual history and malaria treatment prior 
to the visit.
2.2. Collection of samples
  The procedures were adequately explained to the pregnant 
women. After an aseptic preparation, a sterile lancet was 
used to pierce ball of the palmar surface of the left thumb. 
  Two capillary tubes, properly labeled for each woman, were 
filled with blood and one end sealed with a plasticin gum for 
determination of packed cell volume.  The average of the two 
values was used for calculation to ensure accuracy.  Several 
samples were assembled in the centrifuge (hematocrit 
machine) and spurned at 5 000 revolutions per minute 
for 5 minutes.  When the machine had rotated to a halt, 
the cover was opened and the PCV read from Hawksleys 
microhaematocrit reader. All the samples were read by one 
of the authors to remove inter-observer errors.  Anemia 
was considered as a packed cell volume below 33% based 
on the World Health Organization recommendation[9,17]. 
The PCV was chosen for this study as against hemoglobin 
concentration because the former is routinely use to screen 
for anemia in most antenatal women in Nigeria and can 
easily be correlated in the clinical settings.   
2.3. Malaria parasite 
  Two glass slides were then labeled for each woman.  Thin 
and thick blood films were prepared and stained with 
Giemsa stain.  These slides were read under oil immersion 
with a 100伊 objective magnification. For negative slides up 
to 300 fields were examined before conclusion was drawn. 
Parasite enumeration was done using the WHO approved 
method[9,17]. Parasite density was determined using Garcia 
parasitemia determination protocol. Thin film: Counting the 
number of infected cell per 1 000 red blood cells. Thick film: 
counting the number infected cell per 1 000 white blood 
cell count. Both thick and thin film were then calculated 
and converted to infection in microliter (毺L) of blood. 
Quantification of parasite density (per microliter) used 
in this study is as follows: Low <10 000; Medium 10 000-
100 000; and high >100 000. To remove observer errors all 
the samples were process by the same laboratory staff and 
supervised by one of the authors.
2.4. Statistical analysis 
  The minimum sample size of 464 women for the study 
was calculated from an earlier pilot study by the authors 
based on a prevalence of malaria parasitemia of 54.0% in 40 
pregnant women at first antenatal visit.  The findings of this 
study were subjected to statistical analysis using EP1 - Info 
2002 statistical software of the Centre for Disease Control 
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and Prevention, Atlanta, USA.A P-value of <0.05 was 
considered significant. 
 
2.5. Exclusion criterion
  The following women were excluded from the study: those 
with symptomatic malaria infections or on treatments for 
other acute medical conditions; immunodeficiency virus 
sero-positive women on or without drugs; patients treated 
for anemia after diagnoses has been established or sickle 
cell disease in pregnancy; those who refuse to give consent. 
Patients  assured of receiving standard care the pregnancy 
despites their refusal to participate in the study.
 
3. Results
  A total of 514 pregnant women participated in the study 
with a mean maternal age of 21.4 years and a gestational age 
at booking of 18.3 weeks. The primigravid women booked at 
significantly lower gestational age than multigravidae (16.2 
weeks vs 21.6 weeks). Most of the women (306, 59.3%) were 
anemic, out of which 60.4% were primigravida, 60.4% (165) 
were primigravida, and 58.5% (141) were multigravida. 
  Table 1 represents severity of anemia and density of 
malaria parasite in pregnant women. A total of 246 (47.9%) 
of the women had medium to high density parasitemia and 
only 35(6.8%) had no parasitemia.  All the 13(2.5%) women 
with severe anemia had medium to high parasite density. In 
208(40.5%) of those without anemia 175(84.1%) had malarial 
parasite in their blood film but with only 1% high density 
parasitemia.
  Out of the 479 (93.2%) women with malaria parasitemia, 
significantly high number among them (88.7%) had taken 
one form of antimalarial drugs or the other. Among those 
without antimalarial drugs 60.3% had higher density 
parasitemia (P<0.001,氈
2=24.8). 
 
4. Discussion
  The incidence of anemia in this study is higher than reports 
from Ibadan in Nigeria and Greytown in South Africa [6] but 
lower than the findings of 71% from Lagos[12] and 67.4% 
in Enugu[7], both in the southern part of Nigeria. The 
prevalence of anemia in pregnancy varies greatly from place 
to place due to a number of factors such as background 
nutritional status of the society, high parity, infections (such 
as bacteria, helminthes, HIV) and effective utilization of 
other reproductive health facilities by the women[2,3,5,7,15] 
The factors that influence the prevalence of anemia in this 
study is not very clear and may not be a true reflection of 
prevalence in our society. The  prevalence  in this study 
appear to be high because most of our women registered in 
the second trimester when malaria tend to cause anemia 
(mostly between 16 - 29th weeks of pregnancy) which may 
develop suddenly in severe parasitemia and  persist into 
third trimester[2,5-7,15]. On the contrary, the prevalence in 
this study may be reduced by the fact that many pregnant 
women in Nigeria do not attend antenatal clinics and 
tend to deliver outside orthodox health facilities thereby 
reducing the number with this medical problem in our 
clinic. Also, many patients with possible anemia were 
excluded from this study by certain conditions. These 
findings however, demonstrate the burden of anemia in 
the pregnant population and the impact on maternal and 
perinatal consequences seen in Nigeria[12,15]. Nevertheless, 
the high prevalence of malaria parasitemia in this study 
shows its contribution to anemia during pregnancy[7,8]. Both 
malaria and anemia in pregnancy therefore pose serious 
public health challenge in Akwa Ibom State of Nigeria. 
This study like others[10-12,15] from high malarial areas 
shows high level of asymptomatic malaria parasitemia even 
among those without anemia and the density correlated 
directly with severity of the anemia. It therefore, suggests 
that malaria should not only be considered as important 
etiology factor for anemia but in its severity. Thus, treatment 
with effective antimalarial chemotherapy and subsequent 
parasite clearance would result in improvement in the 
level of anemia before the third trimester or labor. This will 
particularly, be of immense benefits to the primigravidas in 
our state who do not only have higher prevalence of anemia 
and parasitemia but register at earlier gestational age for 
antenatal care than multigravidas counterpart. The high 
prevalence of this symptomatic parasitemia in this study 
suggest that the current preventive measures by government 
do not really reach the target vulnerable populations. Thus, 
more effort is required to enlighten the public. 
  It is of great concern that even though significantly large 
number of pregnant women in this study had taken one 
form of antimalarial therapy or the other during the index 
pregnancy majority of them were still having malaria 
parasitemia. It appears that some of these drugs were 
not prescribed by the medical personnel and may not 
contain effective antimarial agents. Also, with widespread 
antimalarial resistant strains against the common 
plasmodium specie (Plasmodium falciparum) in our 
environment some of the agents may not be potent enough 
to clear these parasites. This is particularly so since most 
of these patients had low density parasitemia. Others have 
also documented that use of over the counter antimicrobial 
agents including herbal preparations without prescriptions 
among our people is common[16]. Most of these patients 
who indulge in self medications cited high cost and non 
availability of the government approved agents as  reasons. 
These findings therefore, suggest that to improve compliance 
Table 1 
Severity of anemia and density of malaria parasite in pregnant women.
PCV %
Density o f malaria parasite (%)
None Low Medium High Total
≤ 32 2 (0.7) 127 (41.5) 161(78.2) 16 (52.6) 306(59.5)
≥  33 33 (15.9) 106 (50.9) 67 (32.2) 2 (1.0) 208(40.5)
Total 35 (6.8) 233 (45.3) 226(43.9) 20 (4.0) 514 (100)
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most the potent safe antimalarial agents can be provided 
free of charge or highly subsidized and made available in 
most common dispensing outlet across the state. 
  In conclusion, the prevalence of anemia and malaria 
parasitemia among pregnant women at booking for antenatal 
care is high in Akwa Ibom State of Nigeria. The commonly 
use antimalaria therapy significantly reduce the number 
patient high density parasitema. It is therefore necessary 
to intensify effort at making the current preventive strategy 
by all involve to reach the vulnerable target populations. In 
particular, more effective antimalarial therapy should given 
free to all pregnant women to reduce the parasitemia and 
consequently anemia.
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